Alpha‐defensins: risk factor for thrombosis in COVID‐19 infection-Reference-Cited by-同舟云学术

Alpha‐defensins: risk factor for thrombosis in COVID‐19 infection

Published:2021-05-30 Issue:1 Volume:194 Page:44-52
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Abdeen Suhair¹,Bdeir Khalil²,Abu‐Fanne Rami³,Maraga Emad³,Higazi Mohamed¹,Khurram Nigar²,Feldman Michael²,Deshpande Charuhas²,Litzky Leslie A.²,Heyman Samuel N.⁴,Montone Kathleen T.²,Cines Douglas B.²⁵,Higazi Abd Al‐Roof¹^ORCID

Affiliation:

1. Department of Clinical Biochemistry Hadassah‐Hebrew University JerusalemIL‐91120Israel

2. Departments of Pathology and Laboratory Medicine University of Pennsylvania Perelman School of Medicine Philadelphia PA19104USA

3. Heart Institute Hillel Yaffe Medical Center Affiliated with Rappaport Faculty of Medicine Technion‐Israel Institute of Technology Haifa Israel

4. Department of Medicine Hadassah University Hospital Mt. Scopus JerusalemIL‐91240Israel

5. Department of Medicine University of Pennsylvania‐ Perelman School of Medicine Philadelphia PA19104USA

Funder

Foundation for the National Institutes of Health

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17503

Reference40 articles.

1. Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19

2. 2020 Cold Spring Harbor Laboratory Press C Bryce Z Grimes E Pujadas A Ahuja ME Beasley R Albrecht Pathophysiology of SARS‐CoV‐2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response

3. The unique characteristics of COVID-19 coagulopathy

4. Targeting potential drivers of COVID-19: Neutrophil extracellular traps

5. Anticoagulation, mortality, bleeding and pathology among patients hospitalized with COVID‐19;Nadkarni N;JAC,2020

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological analysis of the potential pathogenic mechanisms of Infectious COVID-19 and Guillain-Barré syndrome;Frontiers in Immunology;2023-12-05

2. Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production;Clinical Immunology;2023-12

3. Identification and Characterization of RK22, a Novel Antimicrobial Peptide from Hirudinaria manillensis against Methicillin Resistant Staphylococcus aureus;International Journal of Molecular Sciences;2023-08-30

4. Antimicrobial peptides and other potential biomarkers of critical illness in Sars-CoV-2 patients with acute kidney injury;2023-07-09

5. Endothelial dysfunction and immunothrombosis in sepsis;Frontiers in Immunology;2023-04-04